Interleukin-1[beta] inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
Ridker, Paul M MD a,b,*,d; Thuren, Tom MD c,d; Zalewski, Andrew MD c,d; Libby, Peter MD b,d
American Heart Journal.
162(4):597-605, October 2011.
(Format: HTML, PDF)